VIIV HEALTHCARE UK (NO.6) LIMITED
Get an alert when VIIV HEALTHCARE UK (NO.6) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-27 (in 3mo)
Last made up 2025-08-13
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
-£251M
+24.4% vs 2023
Employees
0
Average over period
Profit before tax
£101M
+1,778.5% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £9,697,000 | £109,343,000 | |
| Profit before tax | £5,380,000 | £101,063,000 | |
| Net profit | £4,365,000 | £80,692,000 | |
| Cash | — | — | |
| Total assets less current liabilities | -£113,268,000 | -£219,203,000 | |
| Net assets | -£331,332,000 | -£250,640,000 | |
| Equity | -£331,332,000 | -£250,640,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -8.6% | -49.9% | |
| Gearing (liabilities / total assets) | 1177.2% | 895.6% | |
| Interest cover | 2.25x | 13.21x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. The Directors in their considerations have included operational risks to research and development including the availability of research facilities materials. The Directors have considered the Company's abil”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2021-03-25 | — | — |
| BOWERS, Robert | Director | 2024-04-01 | Aug 1977 | British |
| GRAINGER, Karen Marion | Director | 2018-08-29 | Sep 1978 | Irish |
| HALL, Rebecca Elizabeth | Director | 2024-11-01 | Feb 1982 | British |
| WATERHOUSE, Deborah Jayne | Director | 2018-08-29 | Aug 1967 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANDERSON, Jill Dawn | Director | 2018-08-29 | 2023-03-01 |
| MACDIARMID, Cheryl Faye | Director | 2019-05-03 | 2024-04-01 |
| REINAUD, Gregory Maxime | Director | 2018-08-29 | 2019-02-04 |
| WILKINSON, Neil Richard | Director | 2023-03-01 | 2024-11-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Viiv Healthcare Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-29 | Active |
Filing timeline
Last 20 of 34 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-04 | CH04 | officers | Change corporate secretary company with change date | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2024-11-11 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-18 | AD02 | address | Change sail address company with old address new address | |
| 2024-07-15 | AA | accounts | Accounts with accounts type small | |
| 2024-04-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-11 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-26 | AA | accounts | Accounts with accounts type full | |
| 2023-06-09 | AD02 | address | Change sail address company with new address | |
| 2023-06-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-03-03 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
+24.4%
-£331,332,000 -£250,640,000
-
Employees
—
Not reported
-
Operating profit
+1,027.6%
£9,697,000 £109,343,000
-
Profit before tax
+1,778.5%
£5,380,000 £101,063,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers